Alteogen Signs $365 Million Licensing Deal for Subcutaneous Drug Delivery Platform ALT-B4
Biotechnology firm Alteogen has signed an exclusive technology-transfer agreement worth up to $365 million (approximately 521.
Search results for "platform technology"
Asan Medical Center Introduces Korea’s First Transperineal Robotic Prostate Biopsy System
In prostate cancer diagnostics, minimizing procedural infection risks is as vital as accurately sampling suspicious tissue.
Hanmi Pharmaceutical Unveils Next-Gen Cancer Tech Targeting Tumor Microenvironment
Hanmi Pharmaceutical has unveiled a next-generation cancer technology designed to deliver drugs to the tumor...
Cell and Gene Therapy Advances Take Center Stage at Samsung Joint International Symposium
Leading researchers developing stem cell and extracellular vesicle therapies for sepsis, personalized mRNA vaccines for...
GC Pharma’s Homegrown mRNA Vaccine Advances to Phase 2 Trials
GC Pharma announced on the 11th that South Korea’s Ministry of Food and Drug Safety has approved its Phase 2 clinical...
Robots Respond to ‘Scalpel, Please’: Samsung Medical Center Unveils World-First Dual-Humanoid Surgical Team
Humanoid robots capable of responding to voice commands and handing surgical instruments directly to doctors are...
Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells
South Korean researchers have developed a novel anticancer approach capable of selectively turning off specific...
Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009
Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the...
Skin Aging Is More Than Collagen Loss: GC Green Cross Wellbeing Unveils Next-Gen ECM Booster in the Philippines
When skin begins to sag and lose its glow, many people attribute the change solely to declining collagen.
Hansol Hospital Reaches 200 Single-Port Robotic Surgeries in 8 Months
Hansol Hospital, a colorectal specialty hospital designated by the Ministry of Health and Welfare, announced Sept.